Carolindica introduces a new line of gummies and capsules, featuring various cannabinoids for targeted daytime, nighttime, and broad-spectrum wellness needs. CEO stresses the synergy of CBG, CBC, and CBN for optimal results, now available in stores and online.

Recent rescheduling, expansion in Illinois, tax implications, senior market trends, and industry reactions to Trump administration's move on cannabis reclassification are discussed in this podcast.

Recent federal decision to reschedule marijuana is set to expand the industry, affecting scientific research, regulatory landscape, and ancillary businesses. Stay updated with CNW420 for the latest cannabis industry developments.

Republican lawmakers push bill to prevent federal rescheduling of cannabis, potentially impacting companies like Tilray Brands Inc.

The DEA opens registration for medical marijuana operators following a directive from President Trump, impacting the cannabis industry. Rescheduling marijuana products to Schedule III by the DOJ signals a shift in federal policy. Barney’s Farm Genetics reintroduces classic strains in the U.S. market.

Acting AG reschedules cannabis categories, impacting industry; Barney’s Farm Genetics reintroduces classic strains in U.S., emphasizing genetic stability for consistent performance.

Illinois provides loans ranging from $50,000 to $750,000 to 95 cannabis businesses as part of its social equity program, earning praise from industry players like Green Thumb Industries Inc.

April 20th marks a day of celebration and reflection in the cannabis industry, with companies acknowledging the informal holiday. President Trump's executive order may lead to reclassification of marijuana, impacting businesses like Trulieve Cannabis Corp. Meanwhile, a CNN documentary explores medical marijuana's effects on women's health, benefiting companies like Tilray Brands Inc. Piedmont Green Dispensary opens in Charlotte, offering locally sourced hemp products with transparency and education for customers.

Congress proposes allowing states to keep their current regulations for hemp-derived THC products, avoiding a federal ban set for November. Cannabis industry is watching closely.

Idaho supporters, led by industry players like TerrAscend Corp., amass 100,000 signatures for the November ballot by April 30.